nach oben

Reviews in Endocrine and Metabolic Disorders

Erschienen in:

01.04.2019 | Insulins

Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review

verfasst von: Mohammad Zubair, Jamal Ahmad

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

The aim of the review is to examine the role of growth factors and cytokines in the management of Diabetic Foot Ulcers, such as platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and Insulin like growth factor (IGF). Taking this a step further, the role of Hypoxia-inducible factors (HIFs), Transforming growth factor beta 1 (TGF-β-1) and other growth factors have also been examined, with regard to the treatment of diabetic foot ulcers. The roles of these above-mentioned growth cytokines have been analyzed by studying various scholastic articles. The complete process of wound healing is implemented and regulated by numerous cytokines and human growth factors. The findings of the study indicate that wound healing of diabetic foot ulcers is a complex and extremely challenging biological and molecular process that involves coordinated efforts of multiple cell types. The therapeutic effects of various growth factors in the clinical management of wounds are chronic venous ulcers, pressure ulcers, and diabetic foot ulcers. It has been concluded that altercations of various cytokines are found in patients enduring diabetic foot ulcers. In a similar way, changes in the level of cytokines are also found in patients suffering from other diabetic complications such as diabetic nephropathy, retinopathy, and neuropathy. Subsequently, the diabetic wound healing process can be accelerated by regulating the levels of the cytokines.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2007;30:S4–S41.CrossRef

World Health Organization. Accessible at http://www.who.int/diabetes/en/, retrieved on 7 Nov 2018.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRefPubMed

Tuomilehto J, Lindström J, Eriksson JG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed

Pallela SR, Narahari P. A study to find the causes of diabetic foot infections in a selected community. International Surgery Journal. 2017;4(7):2153–56. https://doi.org/10.18203/2349-2902.isj20172576.

American Diabetic Association. (2018). Accessible at: http://www.diabetes.org/diabetes-basics/statistics/. Retrieved on 11 Nov 2018.

Park JW, Hwang SR, Yoon IS. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules. 2017;22(8):1259.CrossRefPubMedCentral

Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes. Cause, effect, or both. Curr Diab Rep. 2014;14:453. https://doi.org/10.1007/s11892-013-0453-1.CrossRefPubMedPubMedCentral

Omanakuttan A, Nambiar J, Harris RM, Bose C, Pandurangan N, Varghese RK, et al. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. Molecular Pharmacology. 2012: Mol-112. https://doi.org/10.1124/mol.112.079020.

10.

Rupert P. Human acellular dermal wound matrix for complex diabetic wounds. J Wound Care. 2016;25:S17–21. https://doi.org/10.12968/jowc.2016.25.sup4.s17.CrossRefPubMed

11.

Crafts TD, Jensen AR, Blocher-Smith EC, Markel TA. Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. Cytokine. 2015;71:385–93. https://doi.org/10.1016/j.cyto.2014.08.005.CrossRefPubMed

12.

Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 2014;22:569–78. https://doi.org/10.1111/j.1524-475x.2008.00410.x.CrossRefPubMedPubMedCentral

13.

Gowda S, Weinstein DA, Blalock TD. Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response. Int Wound J. 2015;12:564–71. https://doi.org/10.1111/iwj.12165.CrossRefPubMed

14.

Heldin C-H, Rönnstrand L. The platelet-derived growth factor receptor. In: Moudgil VK, editor. Receptor phosphorylation. Boca Raton: CRC Press; 1988. p. 149–62.

15.

Kolumam G, Wu X, Lee WP. IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice. PLoS One. 2017;12:e0170639. https://doi.org/10.1371/journal.pone.0170639.CrossRefPubMedPubMedCentral

16.

Gardner JC, Wu H, Noel JG. Keratinocyte growth factor supports pulmonary innate immune defense through the maintenance of alveolar antimicrobial protein levels and macrophage function. Am J Phys Lung Cell Mol Phys. 2016;310:L868–79. https://doi.org/10.1152/ajplung.00363.2015.CrossRef

17.

Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009;153:347–58. https://doi.org/10.1016/j.jss.2008.04.023.CrossRefPubMed

18.

Andersen LP, Holck S, Janulaityte-Günther D. Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without helicobacter pylori infection. FEMS Immunol Med Microbiol. 2005;44:233–8. https://doi.org/10.1016/j.femsim.2004.10.022.CrossRefPubMed

19.

Avitabile OT, Madonna S. Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J Invest Dermatol. 2015;135:2862–70. https://doi.org/10.1038/jid.2015.278.CrossRefPubMed

20.

Kolumam G, Wu X, Lee WP, Hackney JA, Zavala-Solorio J, Gandham V, et al. IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice. PLoS One. 2017;12(1):e0170639.CrossRefPubMedPubMedCentral

21.

Braun AC. Bioresponsive delivery of anticatabolic and anabolic agents for muscle regeneration using bioinspired strategies. Available at https://opus.bibliothek.uni-wuerzburg.de/opus4-wuerzburg/frontdoor/deliver/index/docId/16904/file/Braun_Alexandra_Bioresponsive_delivery.pdf

22.

Costales J, Kolevzon A. The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders. Neurosci Biobehav Rev. 2016;63:207–22.CrossRefPubMedPubMedCentral

23.

Clemmons DR. Role of IGF binding proteins in regulating metabolism. Trends Endocrinol Metab. 2016;27:375–91. https://doi.org/10.1016/j.tem.2016.03.019.CrossRefPubMed

24.

Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6(1):a009191.CrossRefPubMedPubMedCentral

25.

Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14(5):1358–73.CrossRefPubMed

26.

Herder C, Brunner EJ, Rathmann W. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes. The Whitehall II study. Diabetes Care. 2009;32:421–3. https://doi.org/10.2337/dc08-1161.CrossRefPubMedPubMedCentral

27.

El Gazaerly H, Elbardisey DM, Eltokhy HM, Teaama D. Effect of transforming growth factor Beta 1 on wound healing in induced diabetic rats. Int J Health Sci. 2013;7(2):160–72.CrossRef

28.

Chen S, Feng B, Thomas AA, Chakrabarti S. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes. PLoS One. 2017;12(3):e0173918.CrossRefPubMedPubMedCentral

29.

Li Y, Zhang Y, Li X, Shi L, Tao W, Shi L, et al. Association study of polymorphisms in miRNAs with T2DM in a Chinese population. Int J Med Sci. 2015;12(11):875–80.CrossRefPubMedPubMedCentral

30.

Xu J, Wu W, Zhang L. The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes. 2012;61:2906–12. https://doi.org/10.2337/db12-0145.CrossRefPubMedPubMedCentral

31.

Mirza RE, Fang MM, Ennis WJ, Koh TJ. Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes. 2013;62(7):2579–87. https://doi.org/10.2337/db12-1450.CrossRefPubMedPubMedCentral

32.

Robson MC, Payne WG. Growth factor therapy to aid wound healing. Basic and Clinical Dermatology. 2005;33:491.

33.

Arfianti E, Barn V, Pok S, Larter CZ, Teoh NC, Farrell. Diabetes augments obesity in accelerating liver tumor development: role of oxidative stress-induced JNK signaling and DNA damage response. J Hepatol. 2017;66:S78–9. https://doi.org/10.1016/s0168-8278(17)30420-8.CrossRef

34.

Botusan IR, Sunkari VG, Savu O. Stabilization of HIF-1α is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci. 2008;105:19426–31. https://doi.org/10.1073/pnas.0805230105.CrossRefPubMedPubMedCentral

35.

Mueller CG, Hess E. Emerging functions of RANKL in lymphoid tissues. Front Immunol. 2012;3:261. https://doi.org/10.3389/fimmu.2012.00261.CrossRefPubMedPubMedCentral

36.

Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:1–7.CrossRef

37.

Sugimoto M, Furuta T, Shirai N. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol. 2007;22:51–9. https://doi.org/10.1111/j.1440-1746.2006.04442.x.CrossRefPubMed

38.

Liu L, Chen B, Zhang X, Tan L, Wang DW. Increased Cathepsin D correlates with clinical parameters in newly diagnosed type 2 diabetes. Dis Markers. 2017;2017:1–6.

39.

Nowak C, Sundström J, Gustafsson S. Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts. Diabetes. 2016;65:276–84.PubMed

40.

Necchi V, Sommi P, Vanoli A, Fiocca R, Ricci V, Solcia E. Natural history of helicobacter pylori VacA toxin in human gastric epithelium in vivo. Vacuoles and beyond. Sci Rep. 2017;7(1):14526. https://doi.org/10.1038/s41598-017-15204-z.CrossRefPubMedPubMedCentral

41.

Ayuk SM, Abrahamse H, Houreld NN. The role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation. J Diabetes Res. 2016;2016:1–9.CrossRef

42.

Serra R, Gallelli L, Grande R. Hemorrhoids and matrix metalloproteinases: a multicenter study on the predictive role of biomarkers. Surgery. 2016;159:487–94. https://doi.org/10.1016/j.surg.2015.07.003.CrossRefPubMed

43.

Singh K, Agrawal NK, Gupta SK, Mohan G, Chaturvedi S, Singh K. Decreased expression of heat shock proteins may lead to compromised wound healing in type 2 diabetes mellitus patients. J Diabetes Complicat. 2015;29:578–88. https://doi.org/10.1016/j.jdiacomp.2015.01.007.CrossRef

44.

Gruden G, Bruno G, Chaturvedi N. Prospective complications study group. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study. A novel circulating marker for diabetic neuropathy. Diabetes. 2008;57:1966–70. https://doi.org/10.2337/db08-0009.CrossRefPubMedPubMedCentral

45.

Nakhjavani M, Morteza A, Khajeali L. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress Chaperones. 2010;15:959–64. https://doi.org/10.1007/s12192-010-0204-z.CrossRefPubMedPubMedCentral

46.

Zubair M, Ahmad J. Plasma heat shock proteins (HSPs) 70 and 47 levels in diabetic foot and its possible correlation with clinical variables in a north Indian tertiary care hospital. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 2015;9:237–43. https://doi.org/10.1016/j.dsx.2015.02.015.CrossRef

47.

Tsukimi Y, Nakai H, Itoh S, Amagase K, Okabe S. Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol. 2001;52:3. https://doi.org/10.1007/978-94-011-5390-4_28.CrossRef

48.

Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng C. 2015;48:651–62. https://doi.org/10.1016/j.msec.2014.12.068.CrossRef

49.

Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37:1528–42. https://doi.org/10.1177/147323000903700531.CrossRefPubMed

50.

Thiruvoth FM, Mohapatra DP, Sivakumar DK, Chittoria RK, Nandhagopal V. Current concepts in the physiology of adult wound healing. Plast Aesthet Res. 2015;2:250–6. https://doi.org/10.4103/2347-9264.158851.CrossRef

51.

Foy Y, Li J, Kirsner R, Eaglstein W. Analysis of fibroblast defects in extracellular matrix. J Am Acad Dermatol. 2004;50(3):P168.

52.

Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: a clinical review. J Tissue Viability. 2016;25(4):229–36.CrossRefPubMed

53.

Lai JY, Borson ND, Strausbauch MA, Pittelkow MR. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes. Biochem Biophys Res Commun. 2004;316:407–10. https://doi.org/10.1016/j.bbrc.2004.02.065.CrossRefPubMed

54.

Ching YH, Sutton TL, Pierpont YN, Robson MC, Payne WG. The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty. 2011;11.

55.

Larouche J, Sheoran S, Maruyama K, Martino MM. Immune regulation of skin wound healing: mechanisms and novel therapeutic targets. Adv Wound Care. 2018;7:209–31. https://doi.org/10.1089/wound.2017.0761.CrossRef

56.

Bakker AD, Schrooten J, Van Cleynenbreugel T, Vanlauwe J, Luyten J, Schepers E, Dubruel P, Schacht E, Lammens J, Luyten FP. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C: Methods. 2008;14(3):251–60. https://doi.org/10.1089/ten.tec.2008.0022.

57.

Pauli A, Valen E, Schier AF. Identifying (non-) coding RNAs and small peptides. Challenges and opportunities. Bioessays. 2015;37:103–12. https://doi.org/10.1002/bies.201400103.CrossRefPubMed

58.

Margolis DJ, Hampton M, Hoffstad O. NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells. Wound Repair Regen. 2017;25:733–6.CrossRefPubMedPubMedCentral

59.

Viswanathan V, Dhamodharan U, Srinivasan V, Rajaram R, Aravindhan V. Single nucleotide polymorphisms in cytokine/chemokine genes are associated with severe infection, ulcer grade and amputation in diabetic foot ulcer. Int J Biol Macromol. 2018;118:1995–2000.CrossRefPubMed

60.

Lindley LE, Stojadinovic O, Pastar I, Tomic-Canic M. Biology and biomarkers for wound healing. Plast Reconstr Surg. 2016;138:18S–28S. https://doi.org/10.1097/prs.0000000000002682.CrossRefPubMedPubMedCentral

61.

Stojadinovic O, Brem H, Vouthounis C. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59–69. https://doi.org/10.1016/s0002-9440(10)62953-7.CrossRefPubMedPubMedCentral

62.

Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Investig. 2007;117(5):1219–22.

63.

Johnson T, Gómez B, McIntyre M, Dubick M, Christy R, Nicholson S, Burmeister D. The cutaneous microbiome and wounds: New molecular targets to promote wound healing. Int J Mol Sci. 2018;19(9):2699.CrossRefPubMedCentral

Titel: Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review
verfasst von: Mohammad Zubair
Jamal Ahmad
Publikationsdatum: 01.04.2019
Verlag: Springer US
Schlagwörter: Insulins
Diabetic Foot
Cytokines
Growth Factors
Insulins
Erschienen in: Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2019
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-019-09492-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis

Correction to: Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?

Can blood glucose value really be referred to as a metabolic parameter?

Nutritional and non-nutritional agents that stimulate white adipose tissue browning

Prader- Willi syndrome: An uptodate on endocrine and metabolic complications

Prolactin and human weight disturbances: A puzzling and neglected association